These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 33975252)

  • 1. Anaerobe-enriched gut microbiota predicts pro-inflammatory responses in pulmonary tuberculosis.
    Naidoo CC; Nyawo GR; Sulaiman I; Wu BG; Turner CT; Bu K; Palmer Z; Li Y; Reeve BWP; Moodley S; Jackson JG; Limberis J; Diacon AH; van Helden PD; Clemente JC; Warren RM; Noursadeghi M; Segal LN; Theron G
    EBioMedicine; 2021 May; 67():103374. PubMed ID: 33975252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptomic Characterization of Tuberculous Sputum Reveals a Host Warburg Effect and Microbial Cholesterol Catabolism.
    Lai RPJ; Cortes T; Marais S; Rockwood N; Burke ML; Garza-Garcia A; Horswell S; Sesay AK; O'Garra A; Young DB; Wilkinson RJ
    mBio; 2021 Dec; 12(6):e0176621. PubMed ID: 34872348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut microbiome contributes to impairment of immunity in pulmonary tuberculosis patients by alteration of butyrate and propionate producers.
    Maji A; Misra R; Dhakan DB; Gupta V; Mahato NK; Saxena R; Mittal P; Thukral N; Sharma E; Singh A; Virmani R; Gaur M; Singh H; Hasija Y; Arora G; Agrawal A; Chaudhry A; Khurana JP; Sharma VK; Lal R; Singh Y
    Environ Microbiol; 2018 Jan; 20(1):402-419. PubMed ID: 29322681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic and Immune Consequences of Antibiotic Related Microbiome Alterations during first-line Tuberculosis Treatment in Bamako, Mali.
    Diallo D; Sun S; Somboro AM; Baya B; Kone A; Diarra B; Nantoume M; Koloma I; Diakite M; Holl J; Maiga AI; Seydi M; Theron G; Hou L; Fodor A; Maiga M
    Res Sq; 2023 Aug; ():. PubMed ID: 37609282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut microbiota associated with pulmonary tuberculosis and dysbiosis caused by anti-tuberculosis drugs.
    Hu Y; Yang Q; Liu B; Dong J; Sun L; Zhu Y; Su H; Yang J; Yang F; Chen X; Jin Q
    J Infect; 2019 Apr; 78(4):317-322. PubMed ID: 30107196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations of gut microbiota in patients with active pulmonary tuberculosis in China: a pilot study.
    Shi W; Hu Y; Ning Z; Xia F; Wu M; Hu YOO; Chen C; Prast-Nielsen S; Xu B
    Int J Infect Dis; 2021 Oct; 111():313-321. PubMed ID: 34481968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic proinflammation after Mycobacterium tuberculosis infection was correlated to the gut microbiome in HIV-uninfected humans.
    Huang SF; Yang YY; Chou KT; Fung CP; Wang FD; Su WJ
    Eur J Clin Invest; 2019 May; 49(5):e13068. PubMed ID: 30620398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Profiling the airway in the macaque model of tuberculosis reveals variable microbial dysbiosis and alteration of community structure.
    Cadena AM; Ma Y; Ding T; Bryant M; Maiello P; Geber A; Lin PL; Flynn JL; Ghedin E
    Microbiome; 2018 Oct; 6(1):180. PubMed ID: 30301469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Gut Microbiome Signatures Discriminate Healthy From Pulmonary Tuberculosis Patients.
    Hu Y; Feng Y; Wu J; Liu F; Zhang Z; Hao Y; Liang S; Li B; Li J; Lv N; Xu Y; Zhu B; Sun Z
    Front Cell Infect Microbiol; 2019; 9():90. PubMed ID: 31001490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Human Microbiome in the Fight Against Tuberculosis.
    Wood MR; Yu EA; Mehta S
    Am J Trop Med Hyg; 2017 Jun; 96(6):1274-1284. PubMed ID: 28719264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The microbiome and tuberculosis: state of the art, potential applications, and defining the clinical research agenda.
    Naidoo CC; Nyawo GR; Wu BG; Walzl G; Warren RM; Segal LN; Theron G
    Lancet Respir Med; 2019 Oct; 7(10):892-906. PubMed ID: 30910543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nutrition, Inflammation, and the Gut Microbiota among Outpatients with Active Tuberculosis Disease in India.
    Huey SL; Yu EA; Finkelstein JL; Glesby MJ; Bonam W; Russell DG; Mehta S
    Am J Trop Med Hyg; 2021 Oct; 105(6):1645-1656. PubMed ID: 34662867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microbiome diversity in the sputum of patients with pulmonary tuberculosis.
    Krishna P; Jain A; Bisen PS
    Eur J Clin Microbiol Infect Dis; 2016 Jul; 35(7):1205-10. PubMed ID: 27142586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastrointestinal microbiota composition predicts peripheral inflammatory state during treatment of human tuberculosis.
    Wipperman MF; Bhattarai SK; Vorkas CK; Maringati VS; Taur Y; Mathurin L; McAulay K; Vilbrun SC; Francois D; Bean J; Walsh KF; Nathan C; Fitzgerald DW; Glickman MS; Bucci V
    Nat Commun; 2021 Feb; 12(1):1141. PubMed ID: 33602926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of gut microbiota in children with pulmonary tuberculosis.
    Li W; Zhu Y; Liao Q; Wang Z; Wan C
    BMC Pediatr; 2019 Nov; 19(1):445. PubMed ID: 31735171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sputum microbiota in tuberculosis as revealed by 16S rRNA pyrosequencing.
    Cheung MK; Lam WY; Fung WY; Law PT; Au CH; Nong W; Kam KM; Kwan HS; Tsui SK
    PLoS One; 2013; 8(1):e54574. PubMed ID: 23365674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
    API Consensus Expert Committee
    J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal profiling of gut microbiome among tuberculosis patients under anti-tuberculosis treatment in China: protocol of a prospective cohort study.
    Shi W; Hu Y; Zheng X; Ning Z; Wu M; Xia F; Prast-Nielsen S; Hu YOO; Xu B
    BMC Pulm Med; 2019 Nov; 19(1):211. PubMed ID: 31711450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-wide expression profiling identifies type 1 interferon response pathways in active tuberculosis.
    Ottenhoff TH; Dass RH; Yang N; Zhang MM; Wong HE; Sahiratmadja E; Khor CC; Alisjahbana B; van Crevel R; Marzuki S; Seielstad M; van de Vosse E; Hibberd ML
    PLoS One; 2012; 7(9):e45839. PubMed ID: 23029268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of HIV on infectiousness of pulmonary tuberculosis: a community study in Zambia.
    Elliott AM; Hayes RJ; Halwiindi B; Luo N; Tembo G; Pobee JO; Nunn PP; McAdam KP
    AIDS; 1993 Jul; 7(7):981-7. PubMed ID: 8357557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.